Cargando…

A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells

Downstream analysis of virus-infected cell samples, such as reverse transcription polymerase chain reaction (RT PCR) or mass spectrometry, often needs to be performed at lower biosafety levels than their actual cultivation, and thus the samples require inactivation before they can be transferred. Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Soh, Timothy K., Pfefferle, Susanne, Wurr, Stephanie, von Possel, Ronald, Oestereich, Lisa, Rieger, Toni, Uetrecht, Charlotte, Rosenthal, Maria, Bosse, Jens B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171616/
https://www.ncbi.nlm.nih.gov/pubmed/37163509
http://dx.doi.org/10.1371/journal.pone.0274065
_version_ 1785039459613409280
author Soh, Timothy K.
Pfefferle, Susanne
Wurr, Stephanie
von Possel, Ronald
Oestereich, Lisa
Rieger, Toni
Uetrecht, Charlotte
Rosenthal, Maria
Bosse, Jens B.
author_facet Soh, Timothy K.
Pfefferle, Susanne
Wurr, Stephanie
von Possel, Ronald
Oestereich, Lisa
Rieger, Toni
Uetrecht, Charlotte
Rosenthal, Maria
Bosse, Jens B.
author_sort Soh, Timothy K.
collection PubMed
description Downstream analysis of virus-infected cell samples, such as reverse transcription polymerase chain reaction (RT PCR) or mass spectrometry, often needs to be performed at lower biosafety levels than their actual cultivation, and thus the samples require inactivation before they can be transferred. Common inactivation methods involve chemical crosslinking with formaldehyde or denaturing samples with strong detergents, such as sodium dodecyl sulfate. However, these protocols destroy the protein quaternary structure and prevent the analysis of protein complexes, albeit through different chemical mechanisms. This often leads to studies being performed in over-expression or surrogate model systems. To address this problem, we generated a protocol that achieves the inactivation of infected cells through ultraviolet (UV) irradiation. UV irradiation damages viral genomes and crosslinks nucleic acids to proteins but leaves the overall structure of protein complexes mostly intact. Protein analysis can then be performed from intact cells without biosafety containment. While UV treatment protocols have been established to inactivate viral solutions, a protocol was missing to inactivate crude infected cell lysates, which heavily absorb light. In this work, we develop and validate a UV inactivation protocol for SARS-CoV-2, HSV-1, and HCMV-infected cells. A fluence of 10,000 mJ/cm(2) with intermittent mixing was sufficient to completely inactivate infected cells, as demonstrated by the absence of viral replication even after three sequential passages of cells inoculated with the treated material. The herein described protocol should serve as a reference for inactivating cells infected with these or similar viruses and allow for the analysis of protein quaternary structure from bona fide infected cells.
format Online
Article
Text
id pubmed-10171616
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-101716162023-05-11 A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells Soh, Timothy K. Pfefferle, Susanne Wurr, Stephanie von Possel, Ronald Oestereich, Lisa Rieger, Toni Uetrecht, Charlotte Rosenthal, Maria Bosse, Jens B. PLoS One Lab Protocol Downstream analysis of virus-infected cell samples, such as reverse transcription polymerase chain reaction (RT PCR) or mass spectrometry, often needs to be performed at lower biosafety levels than their actual cultivation, and thus the samples require inactivation before they can be transferred. Common inactivation methods involve chemical crosslinking with formaldehyde or denaturing samples with strong detergents, such as sodium dodecyl sulfate. However, these protocols destroy the protein quaternary structure and prevent the analysis of protein complexes, albeit through different chemical mechanisms. This often leads to studies being performed in over-expression or surrogate model systems. To address this problem, we generated a protocol that achieves the inactivation of infected cells through ultraviolet (UV) irradiation. UV irradiation damages viral genomes and crosslinks nucleic acids to proteins but leaves the overall structure of protein complexes mostly intact. Protein analysis can then be performed from intact cells without biosafety containment. While UV treatment protocols have been established to inactivate viral solutions, a protocol was missing to inactivate crude infected cell lysates, which heavily absorb light. In this work, we develop and validate a UV inactivation protocol for SARS-CoV-2, HSV-1, and HCMV-infected cells. A fluence of 10,000 mJ/cm(2) with intermittent mixing was sufficient to completely inactivate infected cells, as demonstrated by the absence of viral replication even after three sequential passages of cells inoculated with the treated material. The herein described protocol should serve as a reference for inactivating cells infected with these or similar viruses and allow for the analysis of protein quaternary structure from bona fide infected cells. Public Library of Science 2023-05-10 /pmc/articles/PMC10171616/ /pubmed/37163509 http://dx.doi.org/10.1371/journal.pone.0274065 Text en © 2023 Soh et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Lab Protocol
Soh, Timothy K.
Pfefferle, Susanne
Wurr, Stephanie
von Possel, Ronald
Oestereich, Lisa
Rieger, Toni
Uetrecht, Charlotte
Rosenthal, Maria
Bosse, Jens B.
A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
title A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
title_full A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
title_fullStr A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
title_full_unstemmed A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
title_short A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
title_sort validated protocol to uv-inactivate sars-cov-2 and herpesvirus-infected cells
topic Lab Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171616/
https://www.ncbi.nlm.nih.gov/pubmed/37163509
http://dx.doi.org/10.1371/journal.pone.0274065
work_keys_str_mv AT sohtimothyk avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT pfefferlesusanne avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT wurrstephanie avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT vonposselronald avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT oestereichlisa avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT riegertoni avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT uetrechtcharlotte avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT rosenthalmaria avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT bossejensb avalidatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT sohtimothyk validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT pfefferlesusanne validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT wurrstephanie validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT vonposselronald validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT oestereichlisa validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT riegertoni validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT uetrechtcharlotte validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT rosenthalmaria validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells
AT bossejensb validatedprotocoltouvinactivatesarscov2andherpesvirusinfectedcells